OtherArticle
Bezafibrate at clinically-relevant doses decreases serum/liver triglycerides via down-regulation of SREBP-1c in mice: a novel PPARα-independent mechanism
Takero Nakajima, Naoki Tanaka, Hiroki Kanbe, Atsushi Hara, Yuji Kamijo, Xiaowei Zhang, Frank J. Gonzalez and Toshifumi Aoyama
Molecular Pharmacology January 5, 2009, DOI: https://doi.org/10.1124/mol.108.052928
Takero Nakajima
Naoki Tanaka
Hiroki Kanbe
Atsushi Hara
Yuji Kamijo
Xiaowei Zhang
Frank J. Gonzalez
This is a PDF-only article. The first page of the PDF of this article appears above.
In this issue
OtherArticle
Bezafibrate at clinically-relevant doses decreases serum/liver triglycerides via down-regulation of SREBP-1c in mice: a novel PPARα-independent mechanism
Takero Nakajima, Naoki Tanaka, Hiroki Kanbe, Atsushi Hara, Yuji Kamijo, Xiaowei Zhang, Frank J. Gonzalez and Toshifumi Aoyama
Molecular Pharmacology January 5, 2009, DOI: https://doi.org/10.1124/mol.108.052928
OtherArticle
Bezafibrate at clinically-relevant doses decreases serum/liver triglycerides via down-regulation of SREBP-1c in mice: a novel PPARα-independent mechanism
Takero Nakajima, Naoki Tanaka, Hiroki Kanbe, Atsushi Hara, Yuji Kamijo, Xiaowei Zhang, Frank J. Gonzalez and Toshifumi Aoyama
Molecular Pharmacology January 5, 2009, DOI: https://doi.org/10.1124/mol.108.052928
Jump to section
Related Articles
Cited By...
More in this TOC Section
Similar Articles
Advertisement